SCHEMBL8809783

SCHEMBL8809783

Cc1oncc1C(=O)Nc1ccc2[nH]ccc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 7/20 0.65
▸ NPC1 O15118 6/20 0.65
▸ MAPT P10636 3/20 0.65
▸ MAOA P21397 4/20 0.55
▸ GMNN O75496 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ HTR1A P08908 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ PIM1 P11309 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ SLC6A2 P23975 1/20 0.55
▸ HTR2A P28223 1/20 0.55
▸ AGTR1 P30556 1/20 0.55
▸ CCKBR P32239 1/20 0.55
▸ MC4R P32245 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ THPO P40225 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808812 0.82 NPC1 (0.65) RAB9ANPC1MAOAGMNNLMNA
SCHEMBL8808709 0.79 RAB9A (0.67) RAB9ANPC1MAPTMAOAGMNN
SCHEMBL13524431 0.79 RAB9A (0.71) RAB9ANPC1MAPTMAOAGMNN
SCHEMBL6230239 0.77 RAB9A (0.72) RAB9ANPC1MAOAGMNNLMNA
SCHEMBL9183591 0.76 RAB9A (0.67) RAB9ANPC1MAPTMAOAGMNN
SCHEMBL8812360 0.76 RAB9A (0.70) RAB9ANPC1MAPTMAOAGMNN
SCHEMBL4347943 0.75 NPC1 (0.69) RAB9ANPC1MAPTMAOAPRKCI
SCHEMBL8809866 0.74 RAB9A (0.64) RAB9ANPC1MAPTMAOAGMNN
SCHEMBL13530060 0.74 RAB9A (0.64) RAB9ANPC1MAOAGMNNLMNA
SCHEMBL8812012 0.74 RAB9A (0.64) RAB9ANPC1MAPTMAOAGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527736-B1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AG (DE) 1997-04-16 — — EP claimed
US-5494911-A TREATING LEUKEMIA, SARCOMA, CARCINOMA, LYMPHOMA, SKIN CANCER HOECHST AKTIENGESELLSCHAFT (DE) 1996-02-27 — — US claimed
EP-0527736-A1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS. HOECHST AG (DE) 1993-02-24 — — EP claimed
WO-1991017748-A1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-28 — — WO claimed
EP-0527736-B1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AG (DE) 1997-04-16 — — EP disclosed
US-5532259-A ANTITUMOR HOECHST AKTIENGESELLSCHAFT (DE) 1996-07-02 — — US disclosed
US-5494911-A TREATING LEUKEMIA, SARCOMA, CARCINOMA, LYMPHOMA, SKIN CANCER HOECHST AKTIENGESELLSCHAFT (DE) 1996-02-27 — — US disclosed
WO-1991017748-A1 ISOXAZOLE-4-CARBOXAMIDES AND HYDROXYALKYLIDENE-CYANOACETAMIDES, DRUGS CONTAINING THESE COMPOUNDS AND USE OF SUCH DRUGS HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-28 — — WO disclosed
Send feedback